SBL
CELG

Sargent Bickham Lagudis’s Celgene Corp CELG Stock Holding History

Sargent Bickham Lagudis’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-587
Closed -$58K – 909
2019
Q3 		$58K Hold
587
– – 0.01% 328
2019
Q2 		$54K Hold
587
– – 0.01% 360
2019
Q1 		$55K Hold
587
– – 0.01% 369
2018
Q4 		$38K Hold
587
– – ﹤0.01% 404
2018
Q3 		$53K Hold
587
– – 0.01% 356
2018
Q2 		$47K Sell
587
-1,750
-75% -$145K 0.01% 364
2018
Q1 		$208K Sell
2,337
-64
-3% -$6.14K 0.03% 204
2017
Q4 		$251K Buy
2,401
+1,864
+347% +$210K 0.03% 195
2017
Q3 		$78K Sell
537
-192
-26% -$26.2K 0.01% 306
2017
Q2 		$95K Buy
729
+30
+4% +$3.68K 0.01% 278
2017
Q1 		$87K Hold
699
– – 0.01% 285
2016
Q4 		$81K Sell
699
-375
-35% -$41.8K 0.01% 274
2016
Q3 		$112 Sell
1,074
-535
-33% -$57.9K 0.02% 257
2016
Q2 		$159K Buy
1,609
+65
+4% +$6.72K 0.02% 230
2016
Q1 		$155K Buy
+1,544
New +$159K 0.03% 233

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Sargent Bickham Lagudis's CELG Position: Q4 2019 in Review

Sargent Bickham Lagudis sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 587 shares — an estimated $58K sold.

Sargent Bickham Lagudis first reported a position in CELG in Q1 2016 and held it in 15 quarters. The position peaked at $251K in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Sargent Bickham Lagudis reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Sargent Bickham Lagudis sold 587 Celgene Corp shares in Q4 2019, an estimated $58K.
  • Sargent Bickham Lagudis first reported a position in Celgene Corp in Q1 2016 and held it in 15 quarters.
  • Sargent Bickham Lagudis's Celgene Corp position peaked at $251K in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2019, filed 14 Sep 2021.